The Prevalence of Sarcopenia in Chinese Older Adults: Meta-Analysis and Meta-Regression

Chen, Zi; Li, Wei Ying; Ho, Mandy; Chau, Pui-Hing

doi:10.3390/nu13051441

Cited by 71 publications

(32 citation statements)

References 76 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The prevalence of sarcopenia was estimated in different countries and regions based on the diagnostic criteria. A meta‐analysis 8 suggested that the prevalence of sarcopenia among the elderly in Chinese communities was 12.9% in males and 11.2% in females and varied by diagnostic criteria and regions.…”

Section: Introductionmentioning

confidence: 99%

Sarcopenia and mild cognitive impairment among elderly adults: The first longitudinal evidence from CHARLS

Peng

Ren

et al. 2022

J cachexia sarcopenia muscle

103

View full text Add to dashboard Cite

BackgroundThe association between sarcopenia and mild cognitive impairment (MCI) among elderly adults in China remains unclear. The present study aimed to examine the association based on a nationally representative large-scale survey. Methods The study used two waves of data from China Health and Retirement Longitudinal Study (CHARLS) in 2015 and 2018. All subjects met the inclusion criteria were classified based on Asia Working Group for Sarcopenia 2019 criteria. Aging-associated cognitive decline is used to define MCI, and cognitive function is measured based on four dimensions: orientation, computation, memory, and drawing. OLS and logistic regression model were conducted to analyse the cross-sectional association between sarcopenia and different cognitive functions. Logistic regression model was conducted to analyse the longitudinal association between sarcopenia and MCI. Results Totally, 5715 participants aged over 60 years (43.8% women; mean age 67.3 ± 6.0 years) were enrolled in a cross-sectional association study in 2015, and further 2982 elderly adults were followed up in 2018. During the period, sarcopenia and possible sarcopenia increased from 8.5% to 29.6%. Scores of cognitive and four dimensions (orientation, computation, memory, and drawing) exhibited a decreasing trend from non-sarcopenia to sarcopenia (P < 0.001). In the fully adjusted OLS regression model, scores of four dimensions were lower in possible sarcopenia and sarcopenia groups when compared with the non-sarcopenia group (P < 0.05) respectively. The incidence of MCI was 10.1%, 16.5%, and 24.2% for non-sarcopenia, possible sarcopenia, and sarcopenia groups from 2015 to 2018, with a significantly statistical difference (P < 0.001). Logistic regression model revealed an odds ratio of 1.43 [95% confidence interval (CI): 1.06-1.91, P = 0.017] for the possible sarcopenia group and 1.72 (95% CI: 1.04-2.85, P = 0.035) for sarcopenia group when compared with the non-sarcopenia group. Conclusions Sarcopenia is associated with worse cognitive impairment, which provided new evidence for a strong association that warrants further research into mechanistic insights.

show abstract

Section: Introductionmentioning

confidence: 99%

Sarcopenia and mild cognitive impairment among elderly adults: The first longitudinal evidence from CHARLS

Peng

Ren

et al. 2022

J cachexia sarcopenia muscle

103

View full text Add to dashboard Cite

show abstract

“…A meta-analysis by Chen et al also indicated that the odds of sarcopenia in Chinese men and women 80 years and older were two-to-three times higher than comparable people 60 to 70 years (females, OR= 3.28, 95% CI= 1.09–9.91; males, OR= 2.66, 95% CI= 1.28–5.50). 27 …”

Section: Discussionmentioning

confidence: 99%

Prevalence and Factors Influencing Sarcopenia Among Community-Dwelling Older Adults Using the Asian Working Group for Sarcopenia Definition

He¹,

Song²,

Ma³

et al. 2022

CIA

View full text Add to dashboard Cite

Objective This study aimed to explore the prevalence and impact of related factors for sarcopenia among community-dwelling older people in Chongming district, China, according to the diagnostic criteria of the Asia Working Group for Sarcopenia-2019. Methods We conducted a cross-sectional study from April 2021 to December 2021. Diagnosis of sarcopenia (non-sarcopenia, possible sarcopenia, sarcopenia, and severe sarcopenia) was based on appendicular skeletal muscle mass index, handgrip strength, gait speed, and the 5-time chair stand test. Staff collected all subjects’ clinical and sociodemographic characteristics, cardiovascular disease (CVD) risk factors, inflammatory markers, physical activity (PA), and daily lifestyle activities to identify sarcopenia-related factors. Results A total of 1407 older people aged ≥ 65 years were enrolled into the study (58.7% female). The prevalence of confirmed sarcopenia was 19.6% (17.1% in females and 23.1% in males). The prevalence of possible sarcopenia, sarcopenia, and severe sarcopenia were 19.7% (22.2% in females, 16.2% in males), 11.9% (10.1% in females, 14.5% in males), and 7.7% (7% in females, 8.6% in males), respectively. Increasing age, gender, depression status, and high-fat mass were associated with an increased likelihood of sarcopenia in all subjects. In females, living alone, high-fat mass, lower body mass index (BMI), lower body weight, and have no time spent doing housework increased the likelihood of sarcopenia. In males, depression status, high-fat mass, higher neutrophils-to-lymphocytes ratio (NLR), lower BMI, lower body weight increased the likelihood of sarcopenia. Conclusion Our study showed a high prevalence of sarcopenia among community-dwelling older people in the Chongming district. Detection, prevention, and treatment efforts are needed to reduce the impact of sarcopenia in older, rural communities in China.

show abstract

“…These contradictory results may be attributable to the various restrictions associated with the diagnosis of sarcopenia and CVRF, the disparities between study participants, and the varying ethnic characteristics. In fact, it was showed that the prevalence of sarcopenia varies from 0 to 48%, depending on the background, parameters, and cutoffs of the study population (2,(36)(37)(38). Moreover, there are significant regional differences in the prevalence of CVD, reflecting variances in CVRF between nations and regions.…”

Section: Discussionmentioning

confidence: 99%

Circulating miR-29b decrease in response to sarcopenia in patients with cardiovascular risk factors in older Chinese

Zhang

et al. 2022

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

IntroductionSarcopenia is a clinical syndrome characterized by a progressive and extensive decline in skeletal muscle mass, muscle strength, and function. Sarcopenia and cardiovascular diseases (CVDs) can coexist, which further decreases the quality of life of patients, and increases the mortality rate. MicroRNAs (miRNAs) are unique posttranscriptional regulators of gene expression whose function in aging-related sarcopenia and CVDs has recently begun to unravel. The aim of the present study is to investigate the relationship between sarcopenia and cardiovascular risk factors (CVRF) in the Chinese elderly and describe the circulating miRNAs in sarcopenia patients with the intention of identifying novel diagnostic and therapeutic tools.MethodsThe well-established CVRF of diabetes, hypertension, and dyslipidemia were assessed. Multiple logistic regression analyses and linear regressions were used to evaluate the components of CVRF and the number of CVRF in elderly patients with sarcopenia. Moreover, we used real-time RT-PCR to measure the abundance of the CVRF-related miRNAs in the plasma of a cohort of 93 control and sarcopenia individuals, including miR-29b, miR-181a, and miR-494.ResultsWe found that CVRF was associated with a high prevalence of sarcopenia in elderly Chinese populations After adjusting for potential confounders. Furthermore, hypertension and dyslipidemia, but not diabetes, were found to be significantly associated with sarcopenia. A linear increase in the prevalence of sarcopenia was found to be associated with the number of CVRF components in the elderly population. We found that plasma miR-29b levels were significantly down-regulated in response to sarcopenia in the elderly with CVRF. In particular, there was a remarkable correlation between miR-29b and appendicular skeletal muscle mass (ASM)/height2. Collectively, knowledge of CVRF, particularly hypertension and dyslipidemia, may help predict the risk of sarcopenia in the elderly. Our data also show that circulating miR-29b can be considered as possible biomarkers for sarcopenia, which may also be used in the CVD assessment of these patients.DiscussionWe found that the prevalence of sarcopenia was significantly proportional to the number of CVRF components. In particular, hypertension and dyslipidemia were significantly associated with a higher risk of sarcopenia in the adjusted models. Moreover, our study has been proven that c-miRNAs may be considered as possible biomarkers for sarcopenia as a new diagnostic tool to monitor response to treatment. There is also a pressing need for further research on sarcopenia and CVRF to understand their relationship and mechanism. These can provide more evidence to develop potential interventions to improve clinical outcomes.

show abstract

The Prevalence of Sarcopenia in Chinese Older Adults: Meta-Analysis and Meta-Regression

Cited by 71 publications

References 76 publications

Sarcopenia and mild cognitive impairment among elderly adults: The first longitudinal evidence from CHARLS

Sarcopenia and mild cognitive impairment among elderly adults: The first longitudinal evidence from CHARLS

Prevalence and Factors Influencing Sarcopenia Among Community-Dwelling Older Adults Using the Asian Working Group for Sarcopenia Definition

Circulating miR-29b decrease in response to sarcopenia in patients with cardiovascular risk factors in older Chinese

Contact Info

Product

Resources

About